However, for patients with moderate to severe renal impairment (eGFR < 45 mL/min/1.73 m 2 ), the associations between these apolipoproteins and MACE did not reach statistical significance (Table 3 ).
← all excerpts
Validation of the role of apolipoproteins in coronary artery disease patients with impaired kidney function for prognosis: a prospective cohort study in China.
1
—
—